title: A new option for the treatment of anaphylaxis linked to steroidal neuromuscular blockers: How much value should we grant to case reports?
authors.affiliation: Université Paris-Diderot & Assistance Publique-Hôpitaux de Paris, Département d'Anesthésie et de Réanimation Chirurgicale, Hôpitaux Universitaires Saint-Louis-Lariboisière, 1 Avenue Claude Vellefaux, 75010, Paris, France, benoit.plaud@sls.aphp.fr.
authors.forename: Benoît
authors.initials: B
authors.lastname: Plaud
mesh_terms: D000707:Anaphylaxis / Q000188:drug therapy*; D000732:Androstanols / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000627:therapeutic use*
chemical_list: D000732:Androstanols; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D000077123:Rocuronium